Skip to content
GLP-1 Scorecard
Menu
Site position #213

Fifty 410

Published by GLP-1 ScorecardUpdated

Fifty 410 is a direct-to-consumer weight-loss telehealth service offering personalized compounded semaglutide and tirzepatide prescribed by licensed providers and prepared by FDA-registered 503A and 503B pharmacies.

Visit Fifty 410We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$99/mo (all doses, compounded)
Tirzepatide
$133/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh Fifty 410 against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value86/100
Dose & formulation72/100
Clinical oversight55/100
Labs & monitoring53/100
Fulfillment71/100
Contract terms37/100

Strengths

  • Transparent public pricing from 99 dollars per month for semaglutide
  • No membership or subscription; pay only for what you need
  • Compounded by FDA-registered 503A and 503B pharmacies
  • Fast 24 to 48 hour provider review
  • Free one to two day shipping

What to consider

  • Does not bill insurance directly
  • Compounded GLP-1 is not an FDA-approved finished drug
  • Specific clinician credentials are not publicly disclosed
  • Served-states list is not published on the site
  • FDA issued Aspen Aesthetics dba Fifty 410 a warning letter in February 2026; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Budget-focused buyers wanting transparent no-membership compounded GLP-1 pricing.

Site position #213 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to Aspen Aesthetics dba Fifty 410 in February 2026. See the FDA warning-letter database.

Closest here

The rankings grading nearest Fifty 410 — the realistic shortlist.

The 18 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Fifty 410's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Fifty 410's site. Not medical advice; see our disclosure.

← Back to the scorecard